AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

NanJing Pharmaceutical Company Limited

¥5.1 -$0.42 (-7.61%)
SHH · 15 Sep 2026 07:00 UTC
Previous Close
¥5.24
Day Range
¥5.09¥5.26
Year Range
¥4.81¥6.65
Market Cap
6.67B
AVG Volume
13.41M
Trailing/Forward PE
10.59/-
PEG ratio
0.62
Dividend Yield
3.33%
Next Earnings Date
-
Primary Exchange
Shanghai Stock ExchangeCN
Revenue (CNY)
020B40B60B2016201720182019202020212022202320242025
600713.SS Revenue (CNY) by year
PeriodRevenue (CNY)
202554.96B
202453.7B
202353.59B
202250.22B
202145.12B
202039.82B
201937.16B
201831.3B
201728.81B
201626.72B
Net Income (CNY)
0200M400M600M800M2016201720182019202020212022202320242025
600713.SS Net Income (CNY) by year
PeriodNet Income (CNY)
2025624.83M
2024570.63M
2023577.83M
2022595.67M
2021505.18M
2020376.41M
2019346.92M
2018264.29M
2017232.44M
2016180.27M
Operating Income (CNY)
0500M1B1.5B2016201720182019202020212022202320242025
600713.SS Operating Income (CNY) by year
PeriodOperating Income (CNY)
20251.16B
20241.02B
20231.01B
2022934.32M
2021845.71M
2020676.26M
2019528.72M
2018479.73M
2017425.22M
2016346.96M
EBITDA (CNY)
0500M1B1.5B2B2016201720182019202020212022202320242025
600713.SS EBITDA (CNY) by year
PeriodEBITDA (CNY)
20251.74B
20241.68B
20231.68B
20221.33B
20211.32B
20201.06B
20191.15B
2018932.67M
2017790.85M
2016664.58M
Cash Flows (CNY)
-2B02B4B6B2016201720182019202020212022202320242025
600713.SS Cash Flows (CNY) by year
PeriodCash Flows (CNY)
2025-157.24M
20241.59B
20235.36B
2022307.84M
2021392M
2020-1.4B
2019703.24M
2018-678.42M
201779.42M
2016-436.72M
EPS (CNY)
00.20.40.62016201720182019202020212022202320242025
600713.SS EPS (CNY) by year
PeriodEPS (CNY)
20250.44
20240.44
20230.44
20220.48
20210.49
20200.36
20190.33
20180.26
20170.26
20160.2
Expenses (CNY)
01B2B3BR&DSG&ACapex2016201720182019202020212022202320242025
600713.SS Expenses (CNY) by year
PeriodExpenses (CNY)
2025790.56M
20242.24B
20231.88B
20221.83B
20211.84B
20201.62B
20191.69B
20181.51B
20171.36B
20161.14B
Cash & Debt (CNY)
02.5B5B7.5B10BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
600713.SS Cash & Debt (CNY) by year
PeriodCash & Debt (CNY)
20253.26B
20244.56B
20232.37B
20222.33B
20212.09B
20201.48B
20192.1B
20182.27B
20171.77B
20161.21B
Debt ratios
00.511.5220182019202020212022202320242025
600713.SS Debt ratios by year
PeriodDebt ratios
20250.36
20240.49
20231.72
20220.68
20210.99
20201.19
20190.3
20180.28
Margins
0%2%4%6%8%2016201720182019202020212022202320242025
600713.SS Margins by year
PeriodMargins
20256.15%
20246.25%
20236.17%
20226.48%
20216.5%
20206.33%
20196.61%
20186.61%
20176.43%
20165.88%
Return on Capital
0%2.5%5%7.5%10%2016201720182019202020212022202320242025
600713.SS Return on Capital by year
PeriodReturn on Capital
20257.57%
20247.33%
20237.96%
20228.9%
20219.65%
20207.81%
20197.68%
20186.43%
20177.29%
20165.87%
Shares Outstanding
0500M1B1.5B2016201720182019202020212022202320242025
600713.SS Shares Outstanding by year
PeriodShares Outstanding
20251.3B
20241.31B
20231.31B
20221.3B
20211.02B
20201.03B
20191.05B
20181.04B
2017890.93M
2016888.12M
Dividends (CNY)
00.10.20.32017201820192020202120222023202420252026
600713.SS Dividends (CNY) by year
PeriodDividends (CNY)
20260.26
20250.17
20240.16
20230.14
20220.12
20210.11
20200.1
20190.1
20180.09
20170.04
Book Value Per Share (CNY)
024682016201720182019202020212022202320242025
600713.SS Book Value Per Share (CNY) by year
PeriodBook Value Per Share (CNY)
20256.34
20245.93
20235.54
20225.14
20215.14
20204.68
20194.32
20183.97
20173.58
20163.46
Total Assets (CNY)
010B20B30B40B2016201720182019202020212022202320242025
600713.SS Total Assets (CNY) by year
PeriodTotal Assets (CNY)
202531.43B
202430.67B
202328.51B
202231.65B
202125.89B
202023.41B
201921.97B
201819.55B
201715.93B
201613.96B
PE Ratio
10121416med 11.61Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
600713.SS PE Ratio by year
PeriodPE Ratio
Sep 2610.81
Sep 2610.69
Sep 2610.85
Aug 2610.92
Aug 2610.73
Aug 2611.12
Aug 2610.69
Jul 2610.46
Jul 2610.09
Jul 2610.61
Jul 2610.5
Jul 2610.52
Jun 2610.56
Jun 2610.37
Jun 2610.42
Jun 2610.46
May 2610.44
May 2610.67
May 2610.9
May 2611.15
Apr 2611
Apr 2611.52
Apr 2612.48
Apr 2612.6
Apr 2611.69
Mar 2613.51
Mar 2613.72
Mar 2614.41
Mar 2614.25
Feb 2614.65
Feb 2614.41
Feb 2614.73
Jan 2614.68
Jan 2615.05
Jan 2614.54
Jan 2614.65
Dec 2514.49
Dec 2515.91
Dec 2515.63
Dec 2514.59
Dec 2515.02
Nov 2514.56
Nov 2514.3
Nov 2515.34
Nov 2514.82
Oct 2514.56
Oct 2514.71
Oct 2514.3
Oct 2514.45
Sep 2514.22
Sep 2510.89
Sep 2511.09
Sep 2511.33
Sep 2511.02
Aug 2511.51
Aug 2511.94
Aug 2511.65
Aug 2511.67
Aug 2511.8
Jul 2511.89
Jul 2511.8
Jul 2511.69
Jul 2511.53
Jun 2511.98
Jun 2511.61
Jun 2511.89
Jun 2511.94
May 2511.89
May 2511.73
May 2511.82
May 2511.77
Apr 2511.98
Apr 2511.57
Apr 2511.43
Apr 2510.92
Apr 2511.8
Mar 2511.42
Mar 2511.28
Mar 2511.15
Mar 2510.85
Feb 2510.9
Feb 2510.94
Feb 2511.15
Feb 2511.12
Jan 2511.01
Jan 2510.85
Jan 2510.9
Jan 2510.58
Jan 2510.7
Dec 2411.47
Dec 2411.68
Dec 2412.03
Dec 2411.88
Nov 2411.65
Nov 2411.92
Nov 2411.25
Nov 2411.61
Nov 2411.14
Oct 2410.82
Oct 2410.56
Free Cash Flow Yield
-40%-20%0%20%40%60%med 12.56%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
600713.SS Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-26.06%
Sep 26-26.36%
Sep 26-25.96%
Aug 26-25.81%
Aug 26-26.26%
Aug 26-25.34%
Aug 26-26.36%
Jul 26-26.94%
Jul 26-27.93%
Jul 26-26.57%
Jul 26-26.83%
Jul 26-26.78%
Jun 26-2.38%
Jun 26-2.43%
Jun 26-2.42%
Jun 26-2.41%
May 26-2.41%
May 26-2.36%
May 26-2.31%
May 26-2.26%
Apr 26-2.29%
Apr 26-2.18%
Apr 26-2.02%
Apr 26-2%
Apr 26-2.15%
Mar 26-2.62%
Mar 26-2.58%
Mar 26-2.46%
Mar 26-2.49%
Feb 26-2.42%
Feb 26-2.46%
Feb 26-2.41%
Jan 26-2.42%
Jan 26-2.36%
Jan 26-2.44%
Jan 26-2.42%
Dec 25-2.45%
Dec 251.62%
Dec 251.65%
Dec 251.77%
Dec 251.72%
Nov 251.77%
Nov 251.8%
Nov 251.68%
Nov 251.74%
Oct 251.77%
Oct 251.75%
Oct 251.8%
Oct 251.78%
Sep 251.81%
Sep 2533.74%
Sep 2533.13%
Sep 2532.41%
Sep 2533.33%
Aug 2531.91%
Aug 2530.78%
Aug 2531.54%
Aug 2531.48%
Aug 2531.13%
Jul 2530.89%
Jul 2531.13%
Jul 2531.42%
Jul 2531.85%
Jun 2523.3%
Jun 2524.04%
Jun 2523.48%
Jun 2523.39%
May 2523.48%
May 2523.8%
May 2523.62%
May 2523.71%
Apr 2523.3%
Apr 2524.13%
Apr 2524.43%
Apr 2525.56%
Apr 2523.66%
Mar 2544.7%
Mar 2545.23%
Mar 2545.78%
Mar 2547.01%
Feb 2546.82%
Feb 2546.63%
Feb 2545.78%
Feb 2545.87%
Jan 2546.34%
Jan 2547.01%
Jan 2546.82%
Jan 2548.21%
Jan 2547.71%
Dec 2426.99%
Dec 2426.53%
Dec 2425.74%
Dec 2426.08%
Nov 2426.58%
Nov 2425.98%
Nov 2427.53%
Nov 2426.68%
Nov 2427.81%
Oct 2428.61%
Oct 2429.34%
Price to Sales
0.10.120.140.160.18med 0.13Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
600713.SS Price to Sales by year
PeriodPrice to Sales
Sep 260.12
Sep 260.12
Sep 260.12
Aug 260.12
Aug 260.12
Aug 260.13
Aug 260.12
Jul 260.12
Jul 260.12
Jul 260.12
Jul 260.12
Jul 260.12
Jun 260.12
Jun 260.12
Jun 260.12
Jun 260.12
May 260.12
May 260.12
May 260.12
May 260.13
Apr 260.13
Apr 260.13
Apr 260.14
Apr 260.14
Apr 260.13
Mar 260.13
Mar 260.14
Mar 260.14
Mar 260.14
Feb 260.14
Feb 260.14
Feb 260.15
Jan 260.14
Jan 260.15
Jan 260.14
Jan 260.14
Dec 250.14
Dec 250.16
Dec 250.16
Dec 250.15
Dec 250.15
Nov 250.15
Nov 250.14
Nov 250.16
Nov 250.15
Oct 250.15
Oct 250.15
Oct 250.14
Oct 250.15
Sep 250.14
Sep 250.12
Sep 250.12
Sep 250.12
Sep 250.12
Aug 250.13
Aug 250.13
Aug 250.13
Aug 250.13
Aug 250.13
Jul 250.13
Jul 250.13
Jul 250.13
Jul 250.13
Jun 250.13
Jun 250.12
Jun 250.13
Jun 250.13
May 250.13
May 250.12
May 250.13
May 250.13
Apr 250.13
Apr 250.12
Apr 250.12
Apr 250.12
Apr 250.13
Mar 250.12
Mar 250.12
Mar 250.12
Mar 250.12
Feb 250.12
Feb 250.12
Feb 250.12
Feb 250.12
Jan 250.12
Jan 250.12
Jan 250.12
Jan 250.11
Jan 250.11
Dec 240.12
Dec 240.13
Dec 240.13
Dec 240.13
Nov 240.13
Nov 240.13
Nov 240.12
Nov 240.13
Nov 240.12
Oct 240.12
Oct 240.11
EV/EBITDA
4681012med 8.46Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
600713.SS EV/EBITDA by year
PeriodEV/EBITDA
Sep 268.06
Sep 268.02
Sep 268.08
Aug 268.1
Aug 268.03
Aug 268.17
Aug 268.02
Jul 267.93
Jul 267.8
Jul 267.99
Jul 267.95
Jul 267.96
Jun 265.11
Jun 265.04
Jun 265.06
Jun 265.07
May 265.06
May 265.15
May 265.23
May 265.32
Apr 265.27
Apr 265.45
Apr 265.8
Apr 265.84
Apr 265.51
Mar 2610.24
Mar 2610.31
Mar 2610.54
Mar 2610.49
Feb 2610.62
Feb 2610.54
Feb 2610.65
Jan 2610.63
Jan 2610.75
Jan 2610.58
Jan 2610.62
Dec 2510.57
Dec 258.87
Dec 258.77
Dec 258.42
Dec 258.57
Nov 258.42
Nov 258.33
Nov 258.68
Nov 258.5
Oct 258.42
Oct 258.46
Oct 258.33
Oct 258.38
Sep 258.3
Sep 258.24
Sep 258.31
Sep 258.4
Sep 258.29
Aug 258.46
Aug 258.61
Aug 258.51
Aug 258.52
Aug 258.57
Jul 258.6
Jul 258.57
Jul 258.53
Jul 258.47
Jun 255.81
Jun 255.69
Jun 255.78
Jun 255.8
May 255.78
May 255.73
May 255.76
May 255.74
Apr 255.81
Apr 255.67
Apr 255.63
Apr 255.45
Apr 255.75
Mar 2511.62
Mar 2511.56
Mar 2511.51
Mar 2511.4
Feb 2511.42
Feb 2511.43
Feb 2511.51
Feb 2511.5
Jan 2511.46
Jan 2511.4
Jan 2511.42
Jan 2511.3
Jan 2511.34
Dec 2410.37
Dec 2410.46
Dec 2410.6
Dec 2410.54
Nov 2410.45
Nov 2410.56
Nov 2410.28
Nov 2410.43
Nov 2410.24
Oct 2410.11
Oct 2410
Price/Operating Cashflow
050100150med 3.19Sep 24Jan 25Apr 25Aug 25Nov 25Mar 26Jun 26
600713.SS Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Jun 2670.11
Jun 2668.87
Jun 2669.14
Jun 2669.42
May 2669.28
May 2670.8
May 2672.32
May 2673.98
Apr 2673.02
Apr 2676.47
Apr 2682.83
Apr 2683.66
Apr 2677.58
Mar 26126.9
Mar 26128.89
Mar 26135.38
Mar 26133.88
Feb 26137.62
Feb 26135.38
Feb 26138.37
Jan 26137.87
Jan 26141.36
Jan 26136.62
Jan 26137.62
Dec 25136.12
Dec 2519.12
Dec 2518.77
Dec 2517.53
Dec 2518.05
Nov 2517.49
Nov 2517.18
Nov 2518.43
Nov 2517.8
Oct 2517.49
Oct 2517.67
Oct 2517.18
Oct 2517.35
Sep 2517.08
Sep 252.64
Sep 252.69
Sep 252.75
Sep 252.67
Aug 252.79
Aug 252.89
Aug 252.82
Aug 252.83
Aug 252.86
Jul 252.88
Jul 252.86
Jul 252.83
Jul 252.8
Jun 253.2
Jun 253.1
Jun 253.17
Jun 253.19
May 253.17
May 253.13
May 253.16
May 253.14
Apr 253.2
Apr 253.09
Apr 253.05
Apr 252.92
Apr 253.15
Mar 251.89
Mar 251.87
Mar 251.85
Mar 251.8
Feb 251.81
Feb 251.81
Feb 251.85
Feb 251.84
Jan 251.82
Jan 251.8
Jan 251.81
Jan 251.75
Jan 251.77
Dec 242.93
Dec 242.98
Dec 243.07
Dec 243.03
Nov 242.97
Nov 243.04
Nov 242.87
Nov 242.96
Nov 242.84
Oct 242.76
Oct 242.69
Oct 242.7
Sep 242.87
Sep 244.11
Sep 243.69
Sep 243.65
Sep 243.8
Aug 243.8
Aug 243.73
Aug 243.95
Aug 243.95
Aug 243.84
Jul 243.73
Price to Book
0.70.80.911.11.2med 0.87Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
600713.SS Price to Book by year
PeriodPrice to Book
Sep 260.79
Sep 260.79
Sep 260.8
Aug 260.8
Aug 260.79
Aug 260.82
Aug 260.79
Jul 260.77
Jul 260.74
Jul 260.78
Jul 260.77
Jul 260.77
Jun 260.8
Jun 260.79
Jun 260.79
Jun 260.79
May 260.79
May 260.81
May 260.82
May 260.84
Apr 260.83
Apr 260.87
Apr 260.94
Apr 260.95
Apr 260.88
Mar 260.9
Mar 260.92
Mar 260.96
Mar 260.95
Feb 260.98
Feb 260.96
Feb 260.98
Jan 260.98
Jan 261
Jan 260.97
Jan 260.98
Dec 250.97
Dec 251.12
Dec 251.1
Dec 251.02
Dec 251.05
Nov 251.02
Nov 251
Nov 251.08
Nov 251.04
Oct 251.02
Oct 251.03
Oct 251
Oct 251.01
Sep 251
Sep 250.8
Sep 250.82
Sep 250.83
Sep 250.81
Aug 250.85
Aug 250.88
Aug 250.86
Aug 250.86
Aug 250.87
Jul 250.87
Jul 250.87
Jul 250.86
Jul 250.85
Jun 250.88
Jun 250.85
Jun 250.87
Jun 250.87
May 250.87
May 250.86
May 250.87
May 250.86
Apr 250.88
Apr 250.85
Apr 250.84
Apr 250.8
Apr 250.86
Mar 250.88
Mar 250.87
Mar 250.86
Mar 250.83
Feb 250.84
Feb 250.84
Feb 250.86
Feb 250.85
Jan 250.85
Jan 250.83
Jan 250.84
Jan 250.81
Jan 250.82
Dec 240.9
Dec 240.92
Dec 240.95
Dec 240.93
Nov 240.92
Nov 240.94
Nov 240.88
Nov 240.91
Nov 240.88
Oct 240.85
Oct 240.83
NanJing Pharmaceutical Company Limited
600713.SS
Stockpicker

Video analysis: 600713.SS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.